📋 FDA Reference

6f Taiga Guiding Catheter

Medtronic Vascular

Compare similar devices

Summary: The 6f Taiga Guiding Catheter is a medical device used in vascular procedures, primarily by interventional cardiologists and radiologists. It aids in the placement of other devices within the vascular system.

FDA Clearance Information

Pathway ? 510(k)
Number ? K083422 ↗
Decision Date ? February 6, 2009
Product Code ? DQY Catheter, Percutaneous
Device Class ? Class 2
Evidence ? 0 studies

The 6f Taiga Guiding Catheter, manufactured by Medtronic Vascular, was cleared through the FDA 510k pathway on February 6, 2009. It is a Class 2 device under product code DQY.

What It Is

The 6f Taiga Guiding Catheter is a flexible tube designed to navigate the vascular system, providing a conduit for other devices such as stents or balloons. It is typically used in interventional procedures to access and treat areas within the venous system. The catheter's design allows for precise control and positioning, which is crucial for successful outcomes in complex vascular interventions.

FDA-Cleared Indications

  • Used to facilitate the placement of interventional and therapeutic devices within the peripheral vascular system.
  • Intended for percutaneous vascular procedures requiring catheter guidance and device delivery.
  • The FDA clearance is associated with product code DQY, Catheter, Percutaneous, under 21 CFR 870.1250.

Clinical Applications

  • Providing a conduit for guidewires, balloons, stents, and other compatible therapeutic devices during percutaneous vascular procedures.
  • Supporting catheter-based treatment of peripheral vascular narrowing or obstruction when device delivery is required.
  • Accessing and navigating vessels under fluoroscopic or other appropriate imaging guidance.
  • Facilitating placement of therapeutic devices in selected peripheral vascular interventions.

Reported off-label uses

  • Use in venous interventions such as iliac or central venous stent delivery may occur in clinical practice, but the specific use should be confirmed against the current device labeling and institutional policy.
  • Use as an access or delivery catheter in other vascular territories may be considered by clinicians when compatible with the catheter's specifications, although this may be outside the cleared indication.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The 6F size refers to an approximately 2 mm outer diameter; the required sheath, guidewire, and accessory devices must be compatible with the catheter's specifications.
  • The catheter is placed percutaneously through vascular access and advanced under imaging guidance, commonly with local anesthesia and optional moderate sedation.
  • Do not use the catheter if it is damaged, kinked, or incompatible with the intended guidewire or therapeutic device. Follow the current instructions for use for flushing, preparation, and maximum pressure limits.
  • MRI safety depends on the exact catheter model and whether it remains in the patient; consult the current labeling before MRI examination.
  • Potential complications are related to catheterization and the underlying procedure and may include bleeding, hematoma, vessel injury, thrombosis, embolization, infection, contrast reaction, or arrhythmia depending on the access site and treatment.

Procedures that use this device

Frequently Asked Questions

What is the 6f Taiga Guiding Catheter used for?

It is used to facilitate the placement of therapeutic devices within the venous system during vascular procedures.

What specialties typically use this device?

Interventional cardiologists and radiologists commonly use this device in vascular procedures.

What are the FDA-cleared indications?

It is indicated for use in facilitating the placement of devices in the venous system, particularly for treating blockages or narrowing of blood vessels.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you